Of note, high CysLT1 expression is associated with poor prognosis and reduced survival in both colorectal [28] and breast cancer [29], while CysLT2 has been reported to have an anti-tumorigenic effect in colorectal cancer [52]. This evidence concerns the gene CYSLTR2 and breast cancer.